Study on Patients' Assessment of the Quality of Care During Their Treatment for Cholecystectomies at Limoges University Hospital (SATISCHOL)

November 13, 2026 updated by: University Hospital, Limoges

A Prospective Observational Study on Patients' Assessment of the Quality of Care During Their Treatment for Cholecystectomies at Limoges University Hospital

SATISCHOL is a prospective, monocentric observational study designed to assess pain management and quality of care in patients undergoing elective cholecystectomy at Limoges University Hospital, France.

The primary objective is to assess the proportion of patients reporting a visual analogue scale (VAS) pain score below 4 two hours after surgery, in association with the occurrence of no postoperative complication or a grade I early postoperative complication according to the Clavien-Dindo classification, within four weeks after surgery.

Secondary objectives include assessing early postoperative pain, describing postoperative complications and intraoperative pain management techniques, and evaluating changes in patients' quality of life using the Gastrointestinal Quality of Life Index (GIQLI) and EQ-5D-5L questionnaires. Patient-reported experience will also be assessed using a study-specific questionnaire (PREMS).

A total of 70 participants are expected to be enrolled. Patients will be followed for approximately 3 to 6 weeks after surgery.

Study Overview

Detailed Description

Cholecystectomy is one of the most frequently performed surgical procedures worldwide, both in elective and emergency settings. At Limoges University Hospital, 146 elective laparoscopic cholecystectomies were performed in 2024.

Cholecystectomy is indicated for the treatment of various biliary tract conditions, including biliary colic, acute or chronic cholecystitis, gallbladder polyps, gallstone pancreatitis, cholangitis and common bile duct stones.

Laparoscopic cholecystectomy, with achievement of the critical view of safety, is the standard surgical approach.

Patient-reported outcome measures (PROMs) and postoperative satisfaction have become increasingly important in the assessment of surgical outcomes and are considered key components of patient-centred care.

This study aims to assess pain management and quality of care during elective cholecystectomy at Limoges University Hospital.

Postoperative pain will be assessed using the visual analogue scale (VAS) two hours after surgery. Postoperative complications will be recorded and classified according to the Clavien-Dindo classification up to four weeks after surgery.

Intraoperative pain management techniques, including trocar-site infiltration, diaphragmatic dome infiltration with local anaesthetic and transversus abdominis plane (TAP) block, will also be documented.

Quality of life will be assessed before surgery (T0) and at postoperative follow-up (T2) using the GIQLI and EQ-5D-5L questionnaires. Patient experience will be evaluated at T2 using a study-specific PREMS questionnaire.

Data will be collected prospectively from clinical records and patient-completed questionnaires administered during the preoperative consultation and at the postoperative follow-up consultation, approximately 3 to 6 weeks after surgery.

The study is expected to contribute to the continuous improvement of pain management and quality of care for patients undergoing cholecystectomy at Limoges University Hospital.

Study Type

Observational

Enrollment (Estimated)

70

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients undergoing elective cholecystectomy, laparoscopic surgery or minimally invasive surgery.

Description

Inclusion Criteria:

  • Age 18 years or older.
  • Patients undergoing elective cholecystectomy.
  • Patients undergoing laparoscopic surgery or minimally invasive surgery, including conversion to open laparotomy when necessary.
  • Patients able to complete questionnaires independently or with the assistance of a caregiver.
  • Patients covered by a health insurance scheme.
  • Patients who have not objected to participation in the study.

Exclusion Criteria:

  • Patients undergoing emergency surgery.
  • Patients undergoing cholecystectomy when gallbladder removal is not the primary purpose of the surgical procedure.
  • Patients with a history of chronic gastrointestinal disease.
  • Patients with known gallbladder cancer.
  • Patients scheduled for open laparotomy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: COHORT
  • Time Perspectives: PROSPECTIVE

Cohorts and Interventions

Group / Cohort
Patients undergoing elective cholecystectomy

Adult patients undergoing elective cholecystectomy at Limoges University Hospital

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proportion of patients with a visual analogue scale (VAS) pain
Time Frame: From two hours after surgery to four weeks postoperatively.

Proportion of patients with a visual analogue scale (VAS) pain score below 4 two hours after cholecystectomy, associated with the occurrence of no postoperative complication or a grade I early postoperative complication according to the Clavien-Dindo classification, within four weeks after surgery.

From two hours after surgery to four weeks postoperatively.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proportion of patients with a VAS pain score
Time Frame: Two hours after surgery.

Proportion of patients with a VAS pain score below 4 two hours after cholecystectomy.

Two hours after surgery.
Proportion of patients experiencing early postoperative complications
Time Frame: Up to four weeks after surgery.

Proportion of patients experiencing early postoperative complications, classified according to the Clavien-Dindo classification.

Up to four weeks after surgery.
Description of intraoperative pain management techniques
Time Frame: During surgery

Assessment of intraoperative analgesic techniques used during surgery, including: local anaesthetic infiltration at trocar insertion sites, local anaesthetic infiltration of the diaphragmatic dome, transversus abdominis plane (TAP) block .

For each technique performed, the type of local anaesthetic used and the administered dose will be recorded, where applicable.

During surgery
Change in the total Gastrointestinal Quality of Life Index (GIQLI) score
Time Frame: Preoperative assessment (T0) and postoperative assessment at 3 to 6 weeks (T2).

Change in the total Gastrointestinal Quality of Life Index (GIQLI) score between baseline (T0) and postoperative follow-up (T2)

Preoperative assessment (T0) and postoperative assessment at 3 to 6 weeks (T2).
Change in the EQ-5D-5L visual analogue scale (VAS)
Time Frame: Preoperative assessment (T0) and postoperative assessment at 3 to 6 weeks (T2).

Change in the EQ-5D-5L visual analogue scale (VAS), corresponding to the patient's self-rated health status today, between baseline (T0) and postoperative follow-up (T2).

Preoperative assessment (T0) and postoperative assessment at 3 to 6 weeks (T2).
Description of patient-reported experience using the study-specific PREMS questionnaire
Time Frame: Postoperative assessment at 3 to 6 weeks (T2)

Description of patient-reported experience using the study-specific PREMS questionnaire, analysed item by item.

Postoperative assessment at 3 to 6 weeks (T2)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Niki CHRISTOU, Professor, University Hospital, Limoges

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 13, 2025

Primary Completion (Estimated)

June 13, 2027

Study Completion (Estimated)

June 13, 2028

Study Registration Dates

First Submitted

October 30, 2026

First Submitted That Met QC Criteria

November 13, 2026

First Posted (Actual)

November 17, 2026

Study Record Updates

Last Update Posted (Actual)

November 17, 2026

Last Update Submitted That Met QC Criteria

November 13, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data collected during this study will not be made publicly available. Data will be handled in accordance with applicable data protection regulations and institutional policies.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe